A Complete Response with Daratumumab, Venetoclax, Azacitidine and Dexamethasone in a Heavily Pre-treated, Chemo-refractory Early T-Precursor Acute Lymphoblastic Leukemia/Lymphoma Patient
Annals of Hematology（2025）
Key words
Early T-precursor acute lymphoblastic leukemia/Lymphoma,Daratumumab,Venetoclax,Azacitidine,Dexamethasone,Allogeneic hemopoietic stem cell transplantation
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined